For information about the PRX-03140 Phase 2a data, please call 866-514-2901.

July 24, 2008
EPIX Pharmaceuticals to Present at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease

July 10, 2008
EPIX Pharmaceuticals Announces South Korean Approval of Vasovist(R); Novel Contrast Agent Now Approved for Marketing in 34 Countries

July 2, 2008
EPIX Pharmaceuticals to Present at the Collins Stewart Fourth Annual Growth Conference